Centaurus Financial’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $535K | Sell |
6,834
-94
| -1% | -$7.58K | 0.02% | 562 |
|
|
2026
Q1 | $600K | Buy |
6,928
+151
| +2% | +$14.5K | 0.03% | 475 |
|
|
2025
Q4 | $651K | Sell |
6,777
-3,860
| -36% | -$375K | 0.03% | 443 |
|
|
2025
Q3 | $1.01M | Buy |
10,637
+4,280
| +67% | +$393K | 0.05% | 330 |
|
|
2025
Q2 | $554K | Sell |
6,357
-4
| -0.1% | -$339 | 0.03% | 441 |
|
|
2025
Q1 | $572K | Buy |
6,361
+130
| +2% | +$11.6K | 0.03% | 418 |
|
|
2024
Q4 | $498K | Sell |
6,231
-42
| -0.7% | -$3.64K | 0.03% | 439 |
|
|
2024
Q3 | $565K | Buy |
6,273
+23
| +0.4% | +$1.94K | 0.04% | 390 |
|
|
2024
Q2 | $492K | Buy |
6,250
+1,613
| +35% | +$132K | 0.03% | 396 |
|
|
2024
Q1 | $404K | Buy |
4,637
+352
| +8% | +$30K | 0.03% | 430 |
|
|
2023
Q4 | $353K | Sell |
4,285
-282
| -6% | -$21.5K | 0.03% | 432 |
|
|
2023
Q3 | $358K | Buy |
4,567
+472
| +12% | +$39.5K | 0.03% | 419 |
|
|
2023
Q2 | $361K | Sell |
4,095
-778
| -16% | -$67K | 0.03% | 426 |
|
|
2023
Q1 | $393K | Buy |
4,873
+922
| +23% | +$75.1K | 0.03% | 471 |
|
|
2022
Q4 | $307K | Sell |
3,951
-979
| -20% | -$79.3K | 0.03% | 480 |
|
|
2022
Q3 | $398K | Sell |
4,930
-145
| -3% | -$13K | 0.04% | 407 |
|
|
2022
Q2 | $456K | Sell |
5,075
-242
| -5% | -$24.5K | 0.05% | 389 |
|
|
2022
Q1 | $590K | Sell |
5,317
-1,262
| -19% | -$133K | 0.05% | 393 |
|
|
2021
Q4 | $681K | Buy |
6,579
+1,081
| +20% | +$125K | 0.05% | 361 |
|
|
2021
Q3 | $689K | Buy |
5,498
+3,903
| +245% | +$505K | 0.06% | 344 |
|
|
2021
Q2 | $198K | Buy |
1,595
+133
| +9% | +$16.7K | 0.02% | 675 |
|
|
2021
Q1 | $173K | Buy |
1,462
+106
| +8% | +$12.4K | 0.02% | 636 |
|
|
2020
Q4 | $159K | Buy |
1,356
+187
| +16% | +$20.6K | 0.02% | 608 |
|
|
2020
Q3 | $122K | Buy |
+1,169
| New | +$117K | 0.02% | 567 |
|
|
2020
Q1 | – | Sell |
-1,119
| Closed | -$127K | – | 596 |
|
|
2019
Q4 | $127K | Buy |
+1,119
| New | +$123K | 0.02% | 559 |
|
|
2019
Q3 | – | Sell |
-1,032
| Closed | -$101K | – | 529 |
|
|
2019
Q2 | $101K | Buy |
+1,032
| New | +$94.2K | 0.02% | 580 |
|
|
2018
Q4 | – | Sell |
-1,000
| Closed | -$113K | – | 516 |
|
|
2018
Q3 | $113K | Sell |
1,000
-1,807
| -64% | -$167K | 0.02% | 493 |
|
|
2018
Q2 | $240K | Buy |
+2,807
| New | +$234K | 0.03% | 474 |
|
Other funds holding MDT
Centaurus Financial's MDT Position: Q2 2026 in Review
Centaurus Financial reduced its Medtronic (MDT) stake by 1.4% in Q2 2026, selling an estimated $7.58K and leaving 6,834 shares worth $535K. The position accounts for 0.02% of the portfolio, ranked #562.
Centaurus Financial first reported a position in MDT in Q2 2018 and has held it in 28 quarters since. The position peaked at $1.01M in Q3 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Centaurus Financial held 6,834 shares of Medtronic worth $535K as of Q2 2026.
- Centaurus Financial sold 94 Medtronic shares in Q2 2026, an estimated $7.58K.
- Medtronic made up 0.02% of Centaurus Financial's portfolio in Q2 2026, its #562 holding.
- Centaurus Financial first reported a position in Medtronic in Q2 2018 and has held it in 28 quarters since.
- Centaurus Financial's Medtronic position peaked at $1.01M in Q3 2025.
- 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.